Diet-Induced Microbiome’s Impact on Heart Failure: A Double-Edged Sword

Heart failure (HF) is a debilitating disease with a significant clinical and economic impact worldwide. Multiple factors seem to increase the risk of developing HF, such as hypertension, obesity and diabetes. Since chronic inflammation plays a significant role in HF pathophysiology and gut dysbiosis is associated with low-grade chronic inflammation, the risk of cardiovascular diseases is likely modulated by the gut microbiome (GM). Considerable progress has been made in HF management. However, there is a need to find new strategies to reduce mortality and increase the quality of life, mainly of HFpEF patients, since its prevalence continues to rise. Recent studies validate that lifestyle changes, such as diet modulation, represent a potential therapeutic approach to improve several cardiometabolic diseases, although their effects on the GM and its indirect cardiac impact still warrant further research. Hence, in this paper, we aim to clarify the link between HF and the human microbiome.

[1]  P. Pimentel-Nunes,et al.  Microbiota Modulation in Patients with Metabolic Syndrome , 2022, Nutrients.

[2]  M. Moshiri,et al.  High Exogenous Antioxidant, Restorative Treatment (Heart) for Prevention of the Six Stages of Heart Failure: The Heart Diet , 2022, Antioxidants.

[3]  E. Elinav,et al.  Time‐limited diets and the gut microbiota in cardiometabolic disease , 2022, Journal of diabetes.

[4]  J. Pen,et al.  Gut microbiota in bariatric surgery , 2022, Critical reviews in food science and nutrition.

[5]  C. Reinhardt,et al.  Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease , 2022, Amino Acids.

[6]  S. Larsson,et al.  Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis , 2022, The American journal of clinical nutrition.

[7]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[8]  M. Chamari,et al.  Effect of Paleolithic-based low-carbohydrate vs. moderate-carbohydrate diets with portion-control and calorie-counting on CTRP6, asprosin and metabolic markers in adults with metabolic syndrome: A randomized clinical trial. , 2021, Clinical nutrition ESPEN.

[9]  M. Cintoni,et al.  Influence of Mediterranean Diet on Human Gut Microbiota , 2020, Kompass Nutrition & Dietetics.

[10]  M. Chong,et al.  The Association of Plant-Based Diet With Cardiovascular Disease and Mortality: A Meta-Analysis and Systematic Review of Prospect Cohort Studies , 2021, Frontiers in Cardiovascular Medicine.

[11]  J. Walkowiak,et al.  High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review , 2021, Cells.

[12]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[13]  S. Halvorsen,et al.  Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial , 2021, EBioMedicine.

[14]  M. Carrington,et al.  The Gut Microbiome of Heart Failure With Preserved Ejection Fraction , 2021, Journal of the American Heart Association.

[15]  M. Gariboldi,et al.  Mediterranean Diet to Prevent the Development of Colon Diseases: A Meta-Analysis of Gut Microbiota Studies , 2021, Nutrients.

[16]  R. Tian,et al.  Cardiac Energy Metabolism in Heart Failure , 2021, Circulation research.

[17]  R. Stoehr,et al.  Gut-Derived Metabolite Indole-3-Propionic Acid Modulates Mitochondrial Function in Cardiomyocytes and Alters Cardiac Function , 2021, Frontiers in Medicine.

[18]  N. D. de Roos,et al.  Intermittent fasting contributes to aligned circadian rhythms through interactions with the gut microbiome. , 2021, Beneficial microbes.

[19]  M. Gancarz,et al.  Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases , 2021, Molecules.

[20]  P. Pinton,et al.  Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion , 2021, Biomedicines.

[21]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. , 2021, Circulation.

[22]  Changtao Jiang,et al.  The role of the gut microbiome and its metabolites in metabolic diseases , 2020, Protein & Cell.

[23]  Jie Du,et al.  TMAO: How gut microbiota contributes to heart failure. , 2020, Translational research : the journal of laboratory and clinical medicine.

[24]  J. Januzzi,et al.  Heart Failure With Reduced Ejection Fraction: A Review. , 2020, JAMA.

[25]  P. Bogdański,et al.  You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review , 2020, Nutrients.

[26]  Edoardo Pasolli,et al.  Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake , 2020, Gut.

[27]  M. Dai,et al.  Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis , 2020, Mediators of Inflammation.

[28]  S. O'keefe,et al.  Diet and the Human Gut Microbiome: An International Review , 2020, Digestive Diseases and Sciences.

[29]  T. Ueland,et al.  Low fibre intake is associated with gut microbiota alterations in chronic heart failure , 2020, ESC heart failure.

[30]  C. Reinhardt,et al.  The Gut Microbiota in Cardiovascular Disease and Arterial Thrombosis , 2019, Microorganisms.

[31]  Akshay S. Desai,et al.  Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients with Heart Failure and Reduced Ejection Fraction:PARADIGM-HF. , 2019, Circulation.

[32]  K. Clarke,et al.  A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial. , 2019, The American journal of clinical nutrition.

[33]  J. Ge,et al.  Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis. , 2019, Journal of molecular and cellular cardiology.

[34]  M. Boyce,et al.  Long-term Paleolithic diet is associated with lower resistant starch intake, different gut microbiota composition and increased serum TMAO concentrations , 2019, European Journal of Nutrition.

[35]  A. Bianco,et al.  Ketogenic Diet and Microbiota: Friends or Enemies? , 2019, Genes.

[36]  K. Schenke-Layland,et al.  Cardiac fibrosis - A short review of causes and therapeutic strategies. , 2019, Advanced drug delivery reviews.

[37]  C. Shively,et al.  Gut microbiome-Mediterranean diet interactions in improving host health , 2019, F1000Research.

[38]  N. Barnard,et al.  The Effects of Vegetarian and Vegan Diets on Gut Microbiota , 2019, Front. Nutr..

[39]  E. Dempsey,et al.  Perinatal factors affect the gut microbiota up to four years after birth , 2019, Nature Communications.

[40]  E. Dempsey,et al.  Perinatal factors affect the gut microbiota up to four years after birth , 2019, Nature Communications.

[41]  V. Pazienza,et al.  Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment , 2019, Medicina.

[42]  T. Vatanen,et al.  The Super-Donor Phenomenon in Fecal Microbiota Transplantation , 2019, Front. Cell. Infect. Microbiol..

[43]  P. Voisine,et al.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.

[44]  S. Rampelli,et al.  Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context , 2018, bioRxiv.

[45]  G. Muscogiuri,et al.  Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome , 2018, Nutrients.

[46]  F. Song,et al.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[47]  W. Dieterich,et al.  Dietary Effects on Microbiota—New Trends with Gluten-Free or Paleo Diet , 2018, Medical sciences.

[48]  Jingli Wang,et al.  Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease , 2018, Circulation research.

[49]  Sanjiv J. Shah,et al.  Meta‐Analysis Global Group in Chronic (MAGGIC) Heart Failure Risk Score: Validation of a Simple Tool for the Prediction of Morbidity and Mortality in Heart Failure With Preserved Ejection Fraction , 2018, Journal of the American Heart Association.

[50]  Sanjiv J. Shah,et al.  The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. , 2018, JACC. Heart failure.

[51]  Danielle M. Enserro,et al.  Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. , 2018, JACC. Heart failure.

[52]  K. Takeda,et al.  Non-Ischemic Heart Failure With Reduced Ejection Fraction Is Associated With Altered Intestinal Microbiota. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[53]  Rob Knight,et al.  Current understanding of the human microbiome , 2018, Nature Medicine.

[54]  L. Kaplan,et al.  The Human Microbiome and Obesity: Moving beyond Associations. , 2017, Cell host & microbe.

[55]  W. Willett,et al.  The Seven Countries Study. , 2017, European heart journal.

[56]  L. Stevenson,et al.  Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction. , 2017, Journal of the American College of Cardiology.

[57]  M. Mattson,et al.  Impact of intermittent fasting on health and disease processes , 2017, Ageing Research Reviews.

[58]  S. R. Ferreira,et al.  Worse inflammatory profile in omnivores than in vegetarians associates with the gut microbiota composition , 2017, Diabetology & Metabolic Syndrome.

[59]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of cardiac failure.

[60]  W. Liao,et al.  Influence of diet on the gut microbiome and implications for human health , 2017, Journal of Translational Medicine.

[61]  E. Noble,et al.  Gut to Brain Dysbiosis: Mechanisms Linking Western Diet Consumption, the Microbiome, and Cognitive Impairment , 2017, Front. Behav. Neurosci..

[62]  A. Gálvez,et al.  The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[63]  W. Lieb,et al.  Heart failure is associated with depletion of core intestinal microbiota , 2017, ESC heart failure.

[64]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[65]  D. Mann,et al.  Neurohormonal activation in heart failure with reduced ejection fraction , 2017, Nature Reviews Cardiology.

[66]  J. L. Ding,et al.  Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists , 2016, Scientific Reports.

[67]  S. Flavahan,et al.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. , 2016, Physiological genomics.

[68]  A. Leite-Moreira,et al.  Mechanisms of Diastolic Dysfunction in Cardiovascular Disease Myocardial reverse remodeling : how far can we rewind ? , 2016 .

[69]  Atsushi Mizoguchi,et al.  Current Understanding of Dysbiosis in Disease in Human and Animal Models , 2016, Inflammatory bowel diseases.

[70]  T. Preston,et al.  Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism , 2016, Gut microbes.

[71]  D. Mozaffarian Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[72]  D. Panagiotakos,et al.  Adherence to Mediterranean diet and 10‐year incidence (2002–2012) of diabetes: correlations with inflammatory and oxidative stress biomarkers in the ATTICA cohort study , 2016, Diabetes/metabolism research and reviews.

[73]  S. Hazen,et al.  Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis , 2015, Cell.

[74]  M. Ufnal,et al.  TMAO: A small molecule of great expectations. , 2015, Nutrition.

[75]  C. Liang,et al.  Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese Individuals , 2015, Circulation. Heart failure.

[76]  F. Levenez,et al.  Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology , 2015, Gut.

[77]  Robert L Pastore,et al.  Paleolithic nutrition improves plasma lipid concentrations of hypercholesterolemic adults to a greater extent than traditional heart-healthy dietary recommendations. , 2015, Nutrition research.

[78]  V. Bhandari,et al.  The Human Neonatal Gut Microbiome: A Brief Review , 2015, Front. Pediatr..

[79]  Knut Rudi,et al.  The composition of the gut microbiota throughout life, with an emphasis on early life , 2015, Microbial ecology in health and disease.

[80]  F. Cao,et al.  The role of the autophagy in myocardial ischemia/reperfusion injury. , 2015, Biochimica et biophysica acta.

[81]  A. Bianco,et al.  Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet , 2015, Marine drugs.

[82]  Brian J. Bennett,et al.  Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation* , 2014, The Journal of Biological Chemistry.

[83]  M. Orlich,et al.  Vegetarian diets in the Adventist Health Study 2: a review of initial published findings. , 2014, The American journal of clinical nutrition.

[84]  A. Wolk,et al.  Processed and Unprocessed Red Meat Consumption and Risk of Heart Failure: Prospective Study of Men , 2014, Circulation. Heart failure.

[85]  Noce Annalisa,et al.  Gut Microbioma Population: An Indicator Really Sensible to Any Change in Age, Diet, Metabolic Syndrome, and Life-Style , 2014, Mediators of inflammation.

[86]  G. Gloor,et al.  Probiotic Administration Attenuates Myocardial Hypertrophy and Heart Failure After Myocardial Infarction in the Rat , 2014, Circulation. Heart failure.

[87]  Jimmy D Bell,et al.  The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism , 2014, Nature Communications.

[88]  F. Bäckhed,et al.  Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits , 2014, Cell.

[89]  Sanjiv J. Shah,et al.  The Emerging Epidemic of Heart Failure with Preserved Ejection Fraction , 2013, Current Heart Failure Reports.

[90]  E. Quigley,et al.  Gut bacteria in health and disease. , 2013, Gastroenterology & hepatology.

[91]  W. Paulus,et al.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. , 2013, Journal of the American College of Cardiology.

[92]  Sean M. Kearney,et al.  Microbial Reprogramming Inhibits Western Diet-Associated Obesity , 2013, PloS one.

[93]  J. Clemente,et al.  The Long-Term Stability of the Human Gut Microbiota , 2013 .

[94]  R. D. de Boer,et al.  Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. , 2013, European heart journal.

[95]  G. Tsujimoto,et al.  The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43 , 2013, Nature Communications.

[96]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[97]  C. Tseng,et al.  Temporal Trends in Treatment and Outcomes for Advanced Heart Failure With Reduced Ejection Fraction From 1993–2010: Findings From a University Referral Center , 2013, Circulation. Heart failure.

[98]  M. Movahed,et al.  Obesity cardiomyopathy and systolic function: Obesity is not independently associated with dilated cardiomyopathy , 2013, Heart Failure Reviews.

[99]  V. Roger,et al.  Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study , 2012, Circulation. Heart failure.

[100]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[101]  Rob Knight,et al.  Defining the human microbiome. , 2012, Nutrition reviews.

[102]  Adrian F Hernandez,et al.  Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction: Prevalence, Therapies, and Outcomes , 2012, Circulation.

[103]  G. Nardone,et al.  Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[104]  D. Jacobs,et al.  The confusion about dietary fatty acids recommendations for CHD prevention. , 2011, The British journal of nutrition.

[105]  R. Vasan,et al.  Epidemiology and clinical course of heart failure with preserved ejection fraction , 2011, European journal of heart failure.

[106]  G. Fonarow,et al.  Epidemiology and risk profile of heart failure , 2011, Nature Reviews Cardiology.

[107]  J. Tap,et al.  Differential Adaptation of Human Gut Microbiota to Bariatric Surgery–Induced Weight Loss , 2010, Diabetes.

[108]  M. G. St. John Sutton,et al.  Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis , 2010, Diabetologia.

[109]  J. Bronzwaer,et al.  Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension , 2008, Circulation.

[110]  F. Shanahan,et al.  Gut microbiota: mining for therapeutic potential. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[111]  R. Gropler,et al.  Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass. , 2006, European heart journal.

[112]  G. Mitchell,et al.  Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[113]  D. Jacobs,et al.  Forty-Year Mortality From Cardiovascular Diseases and All Causes of Death in the US Railroad Cohort of the Seven Countries Study , 2003, European Journal of Epidemiology.

[114]  K. Tuohy,et al.  Using probiotics and prebiotics to improve gut health. , 2003, Drug discovery today.

[115]  F. Shanahan The host-microbe interface within the gut. , 2002, Best practice & research. Clinical gastroenterology.

[116]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[117]  C. Aalkjaer Short chained fatty acids and the colon: how do they cause vasodilatation? , 2002, The Journal of physiology.

[118]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[119]  Tzong-Shyuan Lee,et al.  The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[120]  D. Kromhout,et al.  Diet, prevalence and 10-year mortality from coronary heart disease in 871 middle-aged men. The Zutphen Study. , 1984, American journal of epidemiology.